Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details) - Schedule of convertible notes payable

v3.21.1
Notes Payable (Details) - Schedule of convertible notes payable - USD ($)
 9 Months Ended 12 Months Ended
Mar. 31, 2021
Jun. 30, 2020
Principal [Member]    
Notes Payable (Details) - Schedule of convertible notes payable [Line Items]    
Beginning balance $ 2,935,400 $ 1,748,000
Convertible notes payable issued during fiscal year 822,800 2,148,400
Notes converted into shares of common stock (1,312,000) (961,000)
Debt discount associated with new convertible notes
Amortization of debt discount
True-up adjustment in debt discount and derivative liability  
Ending Balance 2,446,200 2,935,400
Debt Discount [Member]    
Notes Payable (Details) - Schedule of convertible notes payable [Line Items]    
Beginning balance (605,211) (630,259)
Convertible notes payable issued during fiscal year
Notes converted into shares of common stock
Debt discount associated with new convertible notes (512,993) (1,684,711)
Amortization of debt discount 787,216 1,709,759
True-up adjustment in debt discount and derivative liability (37,360)  
Ending Balance (368,348) (605,211)
Net Value [Member]    
Notes Payable (Details) - Schedule of convertible notes payable [Line Items]    
Beginning balance 2,330,189 1,117,741
Convertible notes payable issued during fiscal year 822,800 2,148,400
Notes converted into shares of common stock (1,312,000) (961,000)
Debt discount associated with new convertible notes (512,993) (1,684,711)
Amortization of debt discount 787,216 1,709,759
True-up adjustment in debt discount and derivative liability (37,360)  
Ending Balance $ 2,077,852 $ 2,330,189